Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody.

Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Hodge JW, Schlom J, Kobayashi H.

Oncotarget. 2017 Jan 31;8(5):8807-8817. doi: 10.18632/oncotarget.12410.

2.

Near infrared photoimmunotherapy with an anti-mesothelin antibody.

Nagaya T, Nakamura Y, Sato K, Zhang YF, Ni M, Choyke PL, Ho M, Kobayashi H.

Oncotarget. 2016 Apr 26;7(17):23361-9. doi: 10.18632/oncotarget.8025.

3.

Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody.

Nagaya T, Nakamura Y, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Kobayashi H.

Mol Cancer Res. 2017 Sep;15(9):1153-1162. doi: 10.1158/1541-7786.MCR-17-0164. Epub 2017 Jun 6.

4.

Near infrared photoimmunotherapy using a fiber optic diffuser for treating peritoneal gastric cancer dissemination.

Nagaya T, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Kobayashi H.

Gastric Cancer. 2019 May;22(3):463-472. doi: 10.1007/s10120-018-0871-5. Epub 2018 Aug 31.

PMID:
30171392
5.

Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.

Nagaya T, Sato K, Harada T, Nakamura Y, Choyke PL, Kobayashi H.

PLoS One. 2015 Aug 27;10(8):e0136829. doi: 10.1371/journal.pone.0136829. eCollection 2015.

6.

Near infrared photoimmunotherapy of B-cell lymphoma.

Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Kobayashi H.

Mol Oncol. 2016 Nov;10(9):1404-1414. doi: 10.1016/j.molonc.2016.07.010. Epub 2016 Jul 29.

7.

Endoscopic near infrared photoimmunotherapy using a fiber optic diffuser for peritoneal dissemination of gastric cancer.

Nagaya T, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Kobayashi H.

Cancer Sci. 2018 Jun;109(6):1902-1908. doi: 10.1111/cas.13621. Epub 2018 May 29.

8.

Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).

Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Kobayashi H.

J Control Release. 2016 Jun 28;232:1-8. doi: 10.1016/j.jconrel.2016.04.003. Epub 2016 Apr 5.

9.

Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer.

Harada T, Nakamura Y, Sato K, Nagaya T, Okuyama S, Ogata F, Choyke PL, Kobayashi H.

Oncotarget. 2016 Nov 29;7(48):79408-79416. doi: 10.18632/oncotarget.12710.

10.

Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.

Maruoka Y, Nagaya T, Nakamura Y, Sato K, Ogata F, Okuyama S, Choyke PL, Kobayashi H.

Mol Pharm. 2017 Dec 4;14(12):4628-4635. doi: 10.1021/acs.molpharmaceut.7b00731. Epub 2017 Nov 22.

11.

Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.

Aung W, Tsuji AB, Sugyo A, Takashima H, Yasunaga M, Matsumura Y, Higashi T.

World J Gastroenterol. 2018 Dec 28;24(48):5491-5504. doi: 10.3748/wjg.v24.i48.5491.

12.

Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody.

Nagaya T, Okuyama S, Ogata F, Maruoka Y, Knapp DW, Karagiannis SN, Fazekas-Singer J, Choyke PL, LeBlanc AK, Jensen-Jarolim E, Kobayashi H.

Oncotarget. 2018 Apr 10;9(27):19026-19038. doi: 10.18632/oncotarget.24876. eCollection 2018 Apr 10.

13.

Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.

Ito K, Mitsunaga M, Nishimura T, Saruta M, Iwamoto T, Kobayashi H, Tajiri H.

Bioconjug Chem. 2017 May 17;28(5):1458-1469. doi: 10.1021/acs.bioconjchem.7b00144. Epub 2017 Apr 26.

PMID:
28402624
14.

Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate.

Nagaya T, Gorka AP, Nani RR, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Schnermann MJ, Kobayashi H.

Mol Cancer Ther. 2018 Mar;17(3):661-670. doi: 10.1158/1535-7163.MCT-17-0851. Epub 2017 Dec 13.

15.

Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT.

Nagaya T, Nakamura Y, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Allen C, Kobayashi H.

Mol Cancer Res. 2017 Dec;15(12):1667-1677. doi: 10.1158/1541-7786.MCR-17-0333. Epub 2017 Sep 18.

16.

Real-time monitoring of microdistribution of antibody-photon absorber conjugates during photoimmunotherapy in vivo.

Tang Q, Nagaya T, Liu Y, Lin J, Sato K, Kobayashi H, Chen Y.

J Control Release. 2017 Aug 28;260:154-163. doi: 10.1016/j.jconrel.2017.06.004. Epub 2017 Jun 8.

17.

Near infrared photoimmunotherapy for lung metastases.

Sato K, Nagaya T, Mitsunaga M, Choyke PL, Kobayashi H.

Cancer Lett. 2015 Aug 28;365(1):112-21. doi: 10.1016/j.canlet.2015.05.018. Epub 2015 May 27.

18.

Near infra-red photoimmunotherapy with anti-CEA-IR700 results in extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models of pancreatic cancer.

Maawy AA, Hiroshima Y, Zhang Y, Heim R, Makings L, Garcia-Guzman M, Luiken GA, Kobayashi H, Hoffman RM, Bouvet M.

PLoS One. 2015 Mar 23;10(3):e0121989. doi: 10.1371/journal.pone.0121989. eCollection 2015.

19.

Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.

Sato K, Watanabe R, Hanaoka H, Harada T, Nakajima T, Kim I, Paik CH, Choyke PL, Kobayashi H.

Mol Oncol. 2014 May;8(3):620-32. doi: 10.1016/j.molonc.2014.01.006. Epub 2014 Jan 22.

Supplemental Content

Support Center